[HTML][HTML] US HAEA medical advisory board 2020 guidelines for the management of hereditary angioedema

PJ Busse, SC Christiansen, MA Riedl, A Banerji… - The Journal of Allergy …, 2021 - Elsevier
Scientific and clinical progress together with the development of effective novel therapeutic
options has engendered multiple important changes in the diagnosis and management of …

Urticaria: A comprehensive review: Epidemiology, diagnosis, and work-up

C Antia, K Baquerizo, A Korman, JA Bernstein… - Journal of the American …, 2018 - Elsevier
Urticaria is a common clinical condition presenting with wheals (hives), angioedema, or
both. Urticaria has a complex pathogenesis, along with a high disease burden, a significant …

[HTML][HTML] The international WAO/EAACI guideline for the management of hereditary angioedema–The 2021 revision and update

M Maurer, M Magerl, S Betschel, W Aberer… - World Allergy …, 2022 - Elsevier
Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and
effective therapy are critical. This revision and update of the global WAO/EAACI guideline on …

The international WAO/EAACI guideline for the management of hereditary angioedema–the 2017 revision and update

M Maurer, M Magerl, I Ansotegui… - World Allergy …, 2018 - Springer
Hereditary Angioedema (HAE) is a rare and disabling disease. Early diagnosis and
appropriate therapy are essential. This update and revision of the global guideline for HAE …

Angioedema due to bradykinin dysregulation

M Cicardi, BL Zuraw - The Journal of Allergy and Clinical Immunology: In …, 2018 - Elsevier
Angioedema is an acute swelling of the deeper layers of the skin or mucosa resulting from a
transient increase in vascular permeability. Angioedema can occur in the absence or …

Differences and similarities in the mechanisms and clinical expression of bradykinin-mediated vs. mast cell–mediated angioedema

M Maurer, M Magerl - Clinical Reviews in Allergy & Immunology, 2021 - Springer
Angioedema (AE), transient localized swelling due to extravasated fluid, is commonly
classified as mast cell mediator-induced, bradykinin-mediated or of unknown cause. AE …

Interpretation of serological complement biomarkers in disease

KN Ekdahl, B Persson, C Mohlin, K Sandholm… - Frontiers in …, 2018 - frontiersin.org
Complement system aberrations have been identified as pathophysiological mechanisms in
a number of diseases and pathological conditions either directly or indirectly. Examples of …

The immunopathology of complement proteins and innate immunity in autoimmune disease

F Defendi, NM Thielens, G Clavarino… - Clinical Reviews in …, 2020 - Springer
The complement is a powerful cascade of the innate immunity and also acts as a bridge
between innate and acquired immune defence. Complement activation can occur via three …

Anaesthetic management of patients with pre-existing allergic conditions: a narrative review

P Dewachter, P Kopac, JJ Laguna, PM Mertes… - British journal of …, 2019 - Elsevier
This narrative review seeks to distinguish the clinical patterns of pre-existing allergic
conditions from other confounding non-allergic clinical entities, and to identify the potential …

Bradykinin-mediated angioedema: an update of the genetic causes and the impact of genomics

I Marcelino-Rodriguez, A Callero… - Frontiers in …, 2019 - frontiersin.org
Recurrent episodes of bradykinin-mediated angioedema (Bk-AE) can associate with
acquired or hereditary conditions, the former most commonly developing secondarily to a …